Switch to:
More From Other Websites
Gilead, Merck, Alexion 2017 Views Hazy; Biogen May Surge: Analyst Jan 19 2017
Gilead Sciences: The Biggest Driver Jan 19 2017
Top Analyst Reports for Gilead Sciences, Las Vegas Sands & Illinois Tool Works Jan 19 2017
Verastem's CEO Talks DYNAMO Study, The Competitive Landscape And Pitch To Investors Jan 19 2017
Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen Jan 18 2017
Gilead Sciences: What to Expect When You're Expecting Earnings Jan 18 2017
Gilead’s Hepatitis B Drug Vemlidy Approved In EU Jan 12 2017
Gilead Sciences to Focus on NASH and HIV Drugs Jan 12 2017
Gilead Sciences: Time for Some M&A Flexibility? Jan 12 2017
Biotech Short Sellers Run for Cover Jan 12 2017
Is the Options Market Predicting a Spike in Gilead Sciences (GILD) Stock? Jan 12 2017
Gilead (GILD) HBV Drug Vemlidy Receives European Approval Jan 12 2017
Stock Market Roundup Jan. 11: Health Sector Lower on Trump "Murder" Comment Jan 11 2017
Is Trump the biggest risk to his own rally? Jan 11 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK